Brainomix in collaboration with UK Government-funded NCIMI
Partnership will evaluate AI-powered technology in lung cancer care
Read More
Author: John Pinching
LifeArc and MRC launch toolkit to navigate medicines repurposing
Medicines repurposing offers new avenues for treating a range of common and rare diseases
Read More
Ziphius vaccines and UZ Ghent establish vaccine collaboration
First EU public-private collaboration for production of saRNA-based vaccines
Read More
OPTIMA announce AstraZeneca and Mutabor as official partners
The companies will aim to improve treatment for patients with prostate, breast and lung cancer
Read More
FlyPharma: airea
The Airport Region in Central Germany’ presents itself as an attractive location for the international pharmaceutical industry
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
